RCM Technologies (NASDAQ:RCMT) Posts Earnings Results, Beats Estimates By $0.12 EPS

RCM Technologies logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • RCM Technologies reported quarterly EPS of $0.53, beating the $0.41 consensus by $0.12, while revenue of $73.4 million fell short of analysts’ $78.29 million estimate.
  • Shares fell $4.12 to $30.70 during Thursday trading. Analysts’ average rating was “Moderate Buy,” with an average price target of $45.
  • Company insiders sold nearly 220,000 shares worth about $8.24 million over the past three months.
  • Interested in RCM Technologies? Here are five stocks we like better.

RCM Technologies (NASDAQ:RCMT - Get Free Report) released its earnings results on Thursday. The business services provider reported $0.53 earnings per share for the quarter, beating analysts' consensus estimates of $0.41 by $0.12, FiscalAI reports. RCM Technologies had a net margin of 5.13% and a return on equity of 37.92%. The firm had revenue of $73.40 million for the quarter, compared to analysts' expectations of $78.29 million.

RCM Technologies Stock Performance

Shares of RCM Technologies stock traded down $4.12 during trading hours on Thursday, reaching $30.70. The company had a trading volume of 45,021 shares, compared to its average volume of 65,839. RCM Technologies has a one year low of $17.26 and a one year high of $43.68. The business has a fifty day simple moving average of $38.68 and a 200 day simple moving average of $29.10. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.92 and a quick ratio of 1.92. The firm has a market cap of $218.24 million, a PE ratio of 13.34 and a beta of 0.48.

Insider Activity at RCM Technologies

In other RCM Technologies news, CFO Kevin D. Miller sold 1,753 shares of RCM Technologies stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $42.05, for a total transaction of $73,713.65. Following the completion of the transaction, the chief financial officer owned 330,863 shares of the company's stock, valued at $13,912,789.15. The trade was a 0.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michael Saks sold 706 shares of the company's stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $41.12, for a total value of $29,030.72. Following the sale, the insider owned 88,601 shares in the company, valued at approximately $3,643,273.12. This represents a 0.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 219,997 shares of company stock worth $8,238,837. 28.00% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on RCMT. Zacks Research lowered RCM Technologies from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 13th. Wall Street Zen upgraded RCM Technologies from a "hold" rating to a "strong-buy" rating in a research note on Sunday, August 16th. B. Riley Financial upped their price objective on shares of RCM Technologies from $40.00 to $45.00 and gave the company a "buy" rating in a report on Monday, August 17th. Weiss Ratings lowered shares of RCM Technologies from a "buy (b)" rating to a "hold (c+)" rating in a research report on Monday. Finally, Benchmark lifted their target price on shares of RCM Technologies from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Monday, August 17th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $45.00.

View Our Latest Stock Report on RCMT

RCM Technologies Company Profile

(Get Free Report)

RCM Technologies, Inc. provides business and technology solutions to clients in the United States and other markets. Its services span engineering, specialty health care and life sciences, combining professional expertise with project-based and workforce services. The company's engineering work supports sectors such as aerospace and defense, energy, and industrial manufacturing. Its specialty health care business supplies clinical professionals and related services, while its life sciences business supports pharmaceutical, biotechnology and medical-device organizations with technical and regulatory expertise.

See Also

Earnings History for RCM Technologies (NASDAQ:RCMT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in RCM Technologies Right Now?

Before you consider RCM Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RCM Technologies wasn't on the list.

While RCM Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines